FDA Inspection
Amgen Technology (Ireland) Unlimited CompanyAmgen Technology (Ireland) Unlimited Company – FDA Inspection, Sep 16, 2025
Record Details
This FDA Inspection record concerns Amgen Technology (Ireland) Unlimited Company, with an inspection on September 16, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- September 16, 2025
- Product Type
- Human Drugs
View Company Profile
ID · a1a045e5-0879-4740-b350-4c11ec2de900
Inspection Facts
- Inspection number
- 1278033
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Amgen Technology (Ireland) Unlimited Company
10| Date | Classification | Office | Project area |
|---|---|---|---|
| July 25, 2024 | NAI | Compliance: Devices | |
| September 13, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 16, 2023 | Not classified | Office of Inspections and Investigations | |
| July 28, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 26, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Amgen Technology (Ireland) Unlimited Company
- FDA Inspection 1241641 - 2024-07-25
- FDA Inspection 1221006 - 2023-09-13
- FDA Inspection 1251108 - 2023-08-16
- FDA Inspection 1228800 - 2023-07-28
- FDA Inspection 1114773 - 2018-10-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.